Investigators focused on the potential involvement and mechanism of LINC00337 in breast cancer (BCa). High-expressed LINC00337 accelerated viability and proliferation of BCa cells, improved the resistance of BCa cells to paclitaxel, and accelerated tumor growth.
[Molecular Immunology]
6445218
{6445218:8JFLVVJQ}
apa
50
1
165143
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/